Medicine and Dentistry
Patient
100%
Therapeutic Procedure
40%
Cetuximab
37%
Chemoradiotherapy
34%
Radiation Therapy
31%
Panitumumab
24%
Neck
22%
Cisplatin
22%
Mitogen Activated Protein Kinase 3
21%
Rectum Cancer
20%
Head
18%
Gastrointestinal Toxicity
17%
Calgranulin
17%
Neoplasm
16%
Radiation
16%
Exon
15%
Cervical Cancer
14%
Biological Marker
14%
Pelvic Radiotherapy
14%
Overall Survival
14%
Capecitabine Plus Oxaliplatin
13%
Intestine Function
12%
Preoperative Treatment
12%
Epidermal Growth Factor Receptor
12%
Toxicity
11%
Head and Neck Cancer
10%
Inpatient
10%
Surgery
9%
Capecitabine
8%
Magnetic Resonance Imaging
8%
Feces Incontinence
8%
Deterioration
8%
Global Health
8%
Oxaliplatin
8%
Health Status
8%
Man
8%
Follow up
7%
Analysis
7%
External Beam Radiotherapy
7%
Base
7%
Real-Time Polymerase Chain Reaction
7%
Malignant Neoplasm
7%
Organ
6%
Intensity Modulated Radiation Therapy
6%
Hazard Ratio
6%
Skin
5%
Neoadjuvant Therapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cetuximab
37%
Panitumumab
24%
Cisplatin
22%
Mitogen Activated Protein Kinase 3
21%
Rectum Cancer
20%
Squamous Cell Carcinoma
19%
Transforming Growth Factor
17%
Calgranulin
17%
Chemoradiation Therapy
16%
Neoplasm
16%
Uterine Cervix Cancer
14%
Overall Survival
14%
Capecitabine Plus Oxaliplatin
13%
Symptom
12%
Epidermal Growth Factor Receptor
12%
Head and Neck Cancer
10%
N (6 Aminohexyl) 1 Naphthalenesulfonamide
10%
Feces Incontinence
8%
Health Status
8%
Oxaliplatin
8%
Capecitabine
8%
Deterioration
8%
N (6 Aminohexyl) 5 Chloro 1 Naphthalenesulfonamide
7%
Base
7%
Biochemistry, Genetics and Molecular Biology
Cetuximab
31%
Panitumumab
24%
Cisplatin
22%
Mutation
21%
Life
21%
Oncogene
21%
DNA
17%
Senescence
17%
Dose
17%
Epidermal Growth Factor Receptor
14%
Overall Survival
14%
KRAS
13%
Intestine Function
12%
Volume
10%
Wild Type
10%
Global Health
8%
Health Status
8%
Capecitabine
8%
Radiation
8%
Phenotype
7%
Secretome
7%
Radiation Beam
7%
Cell Proliferation
5%
Electric Potential
5%